Common use

Femara is a potent oral aromatase inhibitor containing the active ingredient letrozole, specifically designed to lower estrogen levels in postmenopausal women. As an effective estrogen blocker, Femara works by inhibiting the aromatase enzyme, which is responsible for converting androgens into estrogen in peripheral tissues. By significantly reducing circulating estrogen levels, this medication helps prevent the growth of estrogen-receptor-positive breast cancer cells that depend on this hormone to proliferate. Femara is primarily prescribed for the treatment of postmenopausal breast cancer, both as initial adjuvant therapy and as extended adjuvant treatment following standard tamoxifen therapy. In addition to its established role in postmenopausal cancer treatment, letrozole has gained widespread recognition as an effective off-label fertility treatment option for women experiencing ovulatory dysfunction, including polycystic ovary syndrome (PCOS). Many patients choose to buy Femara online for its proven efficacy and favorable side effect profile compared to older hormone therapy approaches. Femara generic versions containing the same letrozole active ingredient provide an equally effective and more cost-accessible treatment option for patients requiring long-term aromatase inhibitor therapy.



Dosage and direction

The standard recommended dose of Femara for both adult and elderly patients is 2.5 mg taken once daily by mouth. Swallow the tablet whole with a full glass of water — it can be taken with or without food, at any time of day, though maintaining a consistent schedule is recommended for optimal results. Follow all recommendations provided by your doctor regarding the duration of treatment, which may extend for five years or longer depending on your individual breast cancer treatment plan. Your oncologist may require regular testing to monitor the effectiveness of this aromatase inhibitor, including blood work to assess estrogen levels and tumor markers — do not miss any scheduled appointments. Because letrozole can affect bone health by lowering estrogen, your bone mineral density may also need regular monitoring through DEXA scans, and your doctor may recommend calcium and vitamin D supplementation to help maintain bone strength during long-term hormone therapy. For fertility treatment applications, dosing protocols may differ from cancer treatment — always follow your reproductive endocrinologist's specific instructions when using this estrogen blocker for ovulation induction.



Precautions

Before starting treatment, inform your doctor if you have any history of liver disease, as letrozole is metabolized by the liver and you may require a dose adjustment or additional safety monitoring. Patients with severe hepatic impairment should be closely supervised throughout the course of their hormone therapy. Do not initiate Femara treatment if you are pregnant or suspect pregnancy, as this aromatase inhibitor may cause serious harm to a developing fetus. Women of childbearing potential should confirm a negative pregnancy test before beginning therapy and use highly effective non-hormonal birth control methods throughout the treatment period and for at least three weeks after the final dose. Do not exceed the prescribed amount of letrozole, as higher doses do not improve therapeutic outcomes and may increase the risk of adverse effects. Patients should be aware that this estrogen blocker may cause fatigue, dizziness, and drowsiness, which could affect the ability to drive or operate machinery safely. Report any new or worsening symptoms, particularly bone pain, joint stiffness, or signs of cardiovascular events, to your healthcare provider promptly.



Contraindications

Femara is strictly contraindicated in women who are pregnant, as this aromatase inhibitor may cause fetal harm, birth defects, or pregnancy loss when administered during gestation. Premenopausal women should not use letrozole for breast cancer treatment unless under specific medical supervision with confirmed ovarian suppression. The medication should not be used by individuals with known hypersensitivity to letrozole or any of the inactive ingredients in the formulation. Patients who have not yet reached menopause naturally or through medical intervention should discuss alternative treatment options with their oncologist before attempting to buy letrozole.



Side effects

Treatment with Femara may produce various side effects, some of which are related to the profound reduction of estrogen levels in the body. Common adverse reactions include hot flashes (experienced by a significant proportion of patients), headaches, night sweats, musculoskeletal complaints such as muscle or joint pain and stiffness, fatigue and general weakness, mild weight gain, nausea, and peripheral edema (swelling in the hands, feet, or ankles). You may also experience signs of an allergic reaction, including hives, skin rash, difficulty breathing, or facial swelling — seek immediate medical attention if these occur. Long-term use of this aromatase inhibitor may contribute to decreased bone mineral density and an increased risk of osteoporosis-related fractures, which is why regular bone density monitoring is recommended. Less commonly reported side effects include elevated cholesterol levels, mood changes, insomnia, dizziness, and cardiovascular events. If any adverse reactions worsen or persist, discontinue use and consult your doctor to determine whether continuing hormone therapy with letrozole remains appropriate for your postmenopausal cancer treatment plan.



Drug interaction

The concomitant use of Femara and tamoxifen at a standard daily dose of 20 mg has been shown to lead to a significant decrease in blood concentrations of letrozole, potentially reducing its effectiveness as an estrogen blocker. Caution should be exercised when this aromatase inhibitor is used together with drugs that are metabolized by cytochrome P450 isoenzymes, particularly CYP2A6 and CYP2C19, as competitive inhibition may alter the metabolism of either medication. Inform your doctor about all medications you are taking, including prescription drugs, over-the-counter medicines, herbal products (especially those with estrogenic properties such as soy isoflavones or black cohosh), dietary supplements, and vitamins. Estrogen-containing preparations, including hormone replacement therapy and certain herbal remedies, should be avoided during treatment as they may counteract the therapeutic benefit of this estrogen blocker and reduce the effectiveness of your breast cancer hormone therapy.



Missed dose

If you missed your scheduled dose of Femara, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and return to your regular daily schedule. Never take a double or extra dose of letrozole to compensate for a missed one. Consistent daily adherence is important for maintaining optimal suppression of estrogen levels throughout your treatment. If you frequently forget doses, consider setting a daily alarm or using a pill organizer to help maintain your hormone therapy schedule.



Overdose

A single-dose overdose of Femara is unlikely to produce life-threatening symptoms, though individual responses may vary. If you suspect that you have taken too much letrozole, inform your doctor or contact a poison control center immediately. Treatment of overdose is generally supportive, as there is no specific antidote for this aromatase inhibitor. Medical monitoring may include assessment of vital signs and observation for any adverse effects related to excessive estrogen suppression.



Storage

Store Femara at room temperature between 20-25 C (68-77 F) in a dry location away from excessive moisture, direct heat, and sunlight. Keep the medication in its original packaging until ready to use. Do not store in a bathroom or kitchen where temperature and humidity levels fluctuate. Keep this and all medications securely out of reach of children and pets. Properly dispose of any expired or unused letrozole tablets according to local pharmaceutical waste disposal guidelines.



Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. The content is intended for educational purposes and should not replace professional medical advice. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.